LoginSearch News ArchivesSearch for a SupplierE-Newsletters
Social Media
|
Randox Drug Residues release newly improved Multi-Sulphonamide Testing Platform
publication date: Jul 1, 2011
|
author/source: Randox
 Excellent limits of detection and
simple sample preparations combine to make this product an impressive multi-analyte
testing platform. Limits of detection
for milk range from 0.5-2.5ppb which surpass any tolerance or maximum residue
limits in place from regulatory bodies.
Sample preparations are also available for honey, tissue, urine and
feed, resulting in valuable time savings.
Utilising the revolutionary Biochip Array Technology developed by
Randox, high quality and reliable results are guaranteed. This new testing platform includes the following compounds: Sulphamerazine, Sulphadoxine, Sulphapyridine, Sulphamethoxypyridazine, Sulphachlorpyridazine, Sulphathiazole, Sulphisoxazole, Sulphadimethoxine, Sulphaquinoxaline, Sulphamethazine, Sulphadiazine, Sulphamethizole, Sulphamethoxazole, Sulphamonomethoxine and Trimethoprim. Testing all of these compounds simultaneously offers a more complete and reliable detection method. The Antimicrobial Array I is used in conjunction with the patented Evidence Investigator system which allows for cost effective high throughput screening for a range of drug residues. The Evidence Investigator is a semi-automated biochip analyser. For further information please refer to the Randox Drug Residues website www.drug-residues.com or email drugresidues@randox.com About Randox Drug Residues Randox Drug Residues is dedicated to the development and manufacture of high quality drug residue testing solutions. We use in house developed antibodies and conjugates for a wide range of our screening products including the patented Biochip Array Technology - a proven multiplexing platform. We provide a range of excellent tools for screening for antimicrobials, growth promoting hormones and drugs of abuse in animals and foodstuffs. We offer excellent limit of detections and simple sample preparations. Our portfolio includes 25 ELISA's and 5 multiplex screening platforms. All products are manufactured at our state-of-the-art ISO 13485 accredited manufacturing plant in the UK. |
|
